Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
1,200.00
+4.00 (0.33%)
Oct 12, 2025, 2:24 PM IDT
TLV:REKA Market Cap
TLV:REKA has a market cap or net worth of 136.52 million as of October 13, 2025. Its market cap has decreased by -17.74% in one year.
Market Cap
136.52M
Enterprise Value
267.96M
Revenue
312.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,200.00
Market Cap Chart
Since April 5, 2005, TLV:REKA's market cap has increased from 107.92M to 136.52M, an increase of 26.50%. That is a compound annual growth rate of 1.15%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 12, 2025 | 136.52M | -9.74% |
Dec 31, 2024 | 151.24M | -10.35% |
Dec 31, 2023 | 168.71M | -3.96% |
Dec 29, 2022 | 175.67M | -33.89% |
Dec 30, 2021 | 265.73M | -13.13% |
Dec 31, 2020 | 305.91M | 34.20% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Teva Pharmaceutical Industries | 75.54B |
Danel (Adir Yeoshua) | 3.18B |
Kamada | 1.31B |
Bait Bakfar | 1.04B |
SofWave Medical | 1.01B |
BrainsWay | 953.22M |
Ilex Medical | 725.32M |
Novolog (Pharm-Up 1966) | 662.60M |